Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yuwei A Liu"'
Autor:
Eric L Krakauer, Xiaoxiao J Kwete, Maryam Rassouli, Héctor Arreola-Ornelas, Hadis Ashrafizadeh, Afsan Bhadelia, Yuwei A Liu, Oscar Méndez-Carniado, Hibah Osman, Felicia M Knaul
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 11, p e0001980 (2023)
Integration of palliative care into health care systems is considered an ethical responsibility, yet no country in the Eastern Mediterranean Region (EaMReg) has achieved integration. Data on palliative care need and cost are crucial forEaMReg health
Externí odkaz:
https://doaj.org/article/057d7a067f984c51a7b8c2b6b0832221
Publikováno v:
PLOS Global Public Health. 3:e0001642
This paper describes a Delphi process executed between August and September, 2020, to identify types of physical, psychological, social and spiritual suffering and their severity, prevalence and duration associated with cervical cancer to enable esti
Autor:
Byoung Chul Cho, Myung-Ju Ahn, Yuwei Juliet Liu, Viola W. Zhu, Alexander Drilon, Robert C. Doebele, Jingrong Jean Cui, Dong Wan Kim, Alice T. Shaw, D. Ross Camidge, David M. Hyman, Samuel Ejadi, Jessica J. Lin, Sai-Hong Ignatius Ou, Jeeyun Lee, Shanna Stopatschinskaja
Publikováno v:
Journal of Clinical Oncology. 37:9011-9011
9011 Background: Repotrectinib is a next-generation ROS1/TRK/ALK TKI inhibiting ROS1 with > 90-fold greater potency than crizotinib. Preclinical studies showed robust kinase inhibitory activity of repotrectinib against all known ROS1 fusion positive